These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10570176)

  • 21. CD5 costimulation up-regulates the signaling to extracellular signal-regulated kinase activation in CD4+CD8+ thymocytes and supports their differentiation to the CD4 lineage.
    Zhou XY; Yashiro-Ohtani Y; Toyo-Oka K; Park CS; Tai XG; Hamaoka T; Fujiwara H
    J Immunol; 2000 Feb; 164(3):1260-8. PubMed ID: 10640739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model.
    Ehl S; Hombach J; Aichele P; Hengartner H; Zinkernagel RM
    J Exp Med; 1997 Apr; 185(7):1241-51. PubMed ID: 9104811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
    Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crippling of CD3-zeta ITAMs does not impair T cell receptor signaling.
    Ardouin L; Boyer C; Gillet A; Trucy J; Bernard AM; Nunes J; Delon J; Trautmann A; He HT; Malissen B; Malissen M
    Immunity; 1999 Apr; 10(4):409-20. PubMed ID: 10229184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polarized development of memory cell-like IFN-gamma-producing cells in the absence of TCR zeta-chain.
    Krymskaya L; Lee WH; Zhong L; Liu CP
    J Immunol; 2005 Feb; 174(3):1188-95. PubMed ID: 15661872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3zeta expression.
    Krishnan S; Warke VG; Nambiar MP; Wong HK; Tsokos GC; Farber DL
    Blood; 2001 Jun; 97(12):3851-9. PubMed ID: 11389026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.
    Blank C; Brown I; Marks R; Nishimura H; Honjo T; Gajewski TF
    J Immunol; 2003 Nov; 171(9):4574-81. PubMed ID: 14568931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
    Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T
    J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gfi1:green fluorescent protein knock-in mutant reveals differential expression and autoregulation of the growth factor independence 1 (Gfi1) gene during lymphocyte development.
    Yücel R; Kosan C; Heyd F; Möröy T
    J Biol Chem; 2004 Sep; 279(39):40906-17. PubMed ID: 15252036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.
    Au-Yeung BB; Smith GA; Mueller JL; Heyn CS; Jaszczak RG; Weiss A; Zikherman J
    J Immunol; 2017 Mar; 198(6):2445-2456. PubMed ID: 28159902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness).
    Tham EL; Mescher MF
    J Immunol; 2002 Aug; 169(4):1822-8. PubMed ID: 12165505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different modulation of Ptpn22 in effector and regulatory T cells leads to attenuation of autoimmune diabetes in transgenic nonobese diabetic mice.
    Yeh LT; Miaw SC; Lin MH; Chou FC; Shieh SJ; Chuang YP; Lin SH; Chang DM; Sytwu HK
    J Immunol; 2013 Jul; 191(2):594-607. PubMed ID: 23752610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From naive to memory. Development and regulation of CD4+ T cell responses.
    Carter LL; Swain SL
    Immunol Res; 1998 Aug; 18(1):1-13. PubMed ID: 9724845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LD1: a CD4-CD8- TCR alpha beta/CD3+ peripheral T cell line with helper function for B lymphocytes.
    Pelkonen J; Palacios R
    Int Immunol; 1990; 2(6):555-62. PubMed ID: 2150761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNFB contact sensitivity (CS) in BALB/c and C3H/He mice: requirement for early-occurring, early-acting, antigen-specific, CS-initiating cells with an unusual phenotype (Thy-1+, CD5+, CD3-, CD4-, CD8-, sIg-, B220+, MHC class II-, CD23+, IL-2R-, IL-3R+, Mel-14-, Pgp-1+, J11d+, MAC-1+, LFA-1+, and Fc gamma RII+).
    Ishii N; Takahashi K; Nakajima H; Tanaka S; Askenase PW
    J Invest Dermatol; 1994 Mar; 102(3):321-7. PubMed ID: 7509836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homeostatic regulation of CD8+ T cells by perforin.
    Kägi D; Odermatt B; Mak TW
    Eur J Immunol; 1999 Oct; 29(10):3262-72. PubMed ID: 10540338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of V beta 8.2+ CD4+ T cells induced by a superantigen: roles of antigen-presenting cells and cytokines.
    McKnight AJ; Shea CM; Wiens GR; Rimm IJ; Abbas AK
    Immunology; 1994 Apr; 81(4):513-20. PubMed ID: 7913692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutting Edge: Ikaros null thymocytes mature into the CD4 lineage with reduced TCR signal: A study using CD3{zeta} immunoreceptor tyrosine-based activation motif transgenic mice.
    Urban JA; Brugmann W; Winandy S
    J Immunol; 2009 Apr; 182(7):3955-9. PubMed ID: 19299690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
    Kitamura N; Murata S; Ueki T; Mekata E; Reilly RT; Jaffee EM; Tani T
    Int J Cancer; 2009 Aug; 125(3):630-8. PubMed ID: 19455675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.